Skip to content

Clinical trials

Phase 2 Tuberous Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberous Sclerosis Phase: Phase 2 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20111
20123
20131
20142
20151
20161
20172
20181
20201
20211
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status3
Recruiting2
Terminated2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardiff University2
Dana-Farber Cancer Institute2
Aeovian Pharmaceuticals, Inc.1
Aucta Pharmaceuticals, Inc1
Children's Hospital Medical Center, Cincinnati1
Darcy Krueger1
Holland Bloorview Kids Rehabilitation Hospital1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Longboard Pharmaceuticals1
Marinus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberous Sclerosis21
Epilepsy6
Seizures4
Autistic Disorder3
Angiomyolipoma2
Epilepsies, Myoclonic2
Lennox Gastaut Syndrome2
Lymphangioleiomyomatosis2
22q11 Deletion Syndrome1
Angiofibroma1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.